Latest Advances

  • Condition: Prostate Cancer
  • Journal: Lancet (London, England)
  • Treatment Used: Transdermal Estradiol
  • Number of Patients: 1694
  • Published —
This study tested the safety and efficacy of using transdermal estradiol for prevention of androgen toxicity in patients with prostate cancer.
  • Condition: Advanced Prostate Cancer
  • Journal: Zhonghua nan ke xue = National journal of andrology
  • Treatment Used: Family-Centered Psychological Support
  • Number of Patients: 78
  • Published —
The study researched the outcomes of family-centered psychological support for patients with advanced prostate cancer.
  • Condition: Patients with Endocrine-Related Cancers in COVID-19 Pandemic
  • Journal: Endocrine-related cancer
  • Treatment Used: Cancer Treatment
  • Number of Patients: 0
  • Published —
This article discusses management strategies for patients with tumors of breast, prostate, thyroid, parathyroid and adrenal gland during the COVID-19 pandemic.
  • Condition: Colon, Prostate, and Breast Cancer; Malignant Gliomas; and Cancer Patients on Immunotherapy
  • Journal: Nutrients
  • Treatment Used: Diet
  • Number of Patients: 0
  • Published —
This review of the literature examined evidence for particular diets in cancer patients with colon cancer, prostate cancer, breast cancer, malignant gliomas, and cancer patients on immunotherapy.
  • Condition: Metastatic Pancreatic Carcinoma Associated with Double Heterozygous Germline Mutation in BRCA2 and CHEK2 Gene
  • Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
  • Treatment Used: Chemotherapy
  • Number of Patients: 1
  • Published —
This case report describes a patient diagnosed with metastatic pancreatic adenocarcinoma, associated with double heterozygous germline mutation in BRCA2 and CHEK2 genes treated with first-line FOLFIRINOX chemotherapy.
  • Condition: High Risk Prostate Cancer
  • Journal: Journal of translational medicine
  • Treatment Used: Neoadjuvant Rituximab
  • Number of Patients: 8
  • Published —
This study determined whether neoadjuvant anti-CD20 immunotherapy with rituximab could decrease CD20+?B cell infiltration of prostate tumors in patients with prostate cancer.
  • Condition: Early Prostate Cancer in the Time of COVID-19
  • Journal: La Radiologia medica
  • Treatment Used: Short Fractionation Radiotherapy
  • Number of Patients: 28
  • Published —
This study evaluated stereotactic body radiotherapy (SBRT) in low-risk patients with prostate cancer as preferred treatment option in emergency health conditions.
  • Condition: Lymphoplasmacytic Lymphoma (LPL) in Patient with Chronic Myeloid Leukemia (CML)
  • Journal: Medicine
  • Treatment Used: Long-Term Tyrosine Kinase Inhibitors (TKIs)
  • Number of Patients: 1
  • Published —
This case report describes an 81-year-old male with chronic myeloid leukemia (CML) treated with long-term tyrosine kinase inhibitors (TKIs) who developed lymphoplasmacytic lymphoma (LPL) treated with R-CHOP chemotherapy.
  • Condition: Metastatic Castration-Resistant Prostate Cancer
  • Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
  • Treatment Used: Apalutamide With Abiraterone Acetate Plus Prednisone
  • Number of Patients: 57
  • Published —
The purpose of the study was to evaluate the pharmacokinetics, safety, and antitumor activity of apalutamide combined with abiraterone acetate plus prednisone in patients with metastatic castration-resistant prostate cancer.
  • Condition: Prostate Cancer
  • Journal: Molecular cancer therapeutics
  • Treatment Used: Platinum-Based Chemotherapy
  • Number of Patients: 38
  • Published —
This study assessed the impact of SLFN11 expression on response to platinum chemotherapy and outcomes in patients with metastatic castration-resistant prostate cancer (CRPC).
  • Condition: Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • Journal: European journal of cancer (Oxford, England : 1990)
  • Treatment Used: Abiraterone Acetate
  • Number of Patients: 170
  • Published —
This study reported on the androgen signalling signature associated with a response to androgen signalling inhibition in men with metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone acetate.
  • Condition: Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC)
  • Journal: Annals of oncology : official journal of the European Society for Medical Oncology
  • Treatment Used: Apalutamide
  • Number of Patients: 1207
  • Published —
This study compared whether placebo versus apalutamide added to ongoing androgen deprivation therapy significantly prolonged metastasis-free survival (MFS) and time to symptomatic progression in patients with high-risk non-metastatic castration-resistant prostate cancer (nmCRPC).
Showing 1-12 of 33